Oracle Prices $10 Billion Share Sale at $116 for AI Buildout

Oracle Corp. (ORCL) announced on November 2, 2026, the pricing of concurrent underwritten public offerings totaling $20 billion, to fund its artificial intelligence expansion. The package includes $10 billion of common stock sold at $116.00 per share, an 11.2% discount to the prior close, and $10 billion of senior notes across five tranches.

The common stock offering comprises 86,206,897 shares, with net proceeds of approximately $9.9 billion after underwriting discounts and estimated expenses. The notes offering consists of $2.0 billion of 7.000% notes due 2029, $1.75 billion of 7.450% notes due 2031, $2.25 billion of 7.850% notes due 2033, $2.5 billion of 8.000% notes due 2037, and $1.5 billion of 8.650% notes due 2046, with net proceeds of about $10.0 billion. Both offerings are expected to close on November 4, 2026, subject to customary closing conditions, and neither is contingent on the other.

According to Oracle's press release, the net proceeds will be used for general corporate purposes, which may include capital expenditures, repayment of indebtedness, future investments or acquisitions, and payment of cash dividends on or repurchases of common stock. BofA Securities is acting as sole global coordinator, with Wells Fargo Securities, Citigroup, BNP PARIBAS, Deutsche Bank Securities, J.P. Morgan, PNC Capital Markets LLC, Goldman Sachs & Co. LLC, HSBC and SMBC Nikko as joint book-running managers. BTIG is a joint book-running manager of the common stock offering, while U.S. Bancorp and Lloyds Securities are joint book-running managers of the notes offering. Intesa Sanpaolo, Mizuho, MUFG, TD Securities, Santander, BNY Capital Markets, CIBC Capital Markets and ING are acting as co-managers, and Standard Chartered Bank is a co-manager of the notes offering.

What the financing signals about Oracle's AI bet

GuruFocus reported that the funding adds to Oracle's cash pile as it expands expenditure on cloud capacity and AI technology. For shareholders, the stock sale means dilution, while the bond portion adds leverage and future interest costs, making the cost of finance an increasingly critical part of the investment case as Oracle builds out data centers and related infrastructure.

The offering is in line with management's previous commitment to limit any fundraising through fiscal 2030 to $20 billion, split evenly between equity and debt. Oracle has predicted capital investment should peak in fiscal 2027 and 2028, before trending down in fiscal 2029. That timeline suggests the company expects the heaviest spending to come in the next two fiscal years, after which depreciation and revenue from new capacity should begin to offset the cash outlay.

The interest rates on the notes range from 7.000% on the three-year tranche to 8.650% on the twenty-year tranche, reflecting both the maturity structure and the credit risk premium investors demand for long-dated Oracle debt. The coupon ladder steps up gradually, with each longer tranche carrying a higher rate, which is consistent with a yield curve that compensates investors for holding Oracle paper through the peak investment period.

The open questions

The pricing at an 11.2% discount to the prior close reflects the size of the offering and market conditions at the time. Whether Oracle's cloud growth and future free cash flow can justify the added dilution and debt burden remains to be seen, and the market's reaction to the completion of the offerings on November 4 will provide an early signal.

The net proceeds are earmarked broadly for general corporate purposes, so the exact allocation between AI infrastructure, debt repayment and shareholder returns is not specified in the filing. That flexibility gives management room to adapt, but it also leaves open how quickly the new capital converts into productive capacity. Investors will likely watch Oracle's next earnings report for guidance on how the proceeds are being deployed.

Oracle's press release carried a safe harbor statement noting that statements about the anticipated use of proceeds and the ability to complete the offerings on the anticipated timeline are forward-looking and subject to material risks and uncertainties. All information in the release was current as of November 2, 2026, and Oracle undertook no duty to update any statement in light of new information or future events.